168 related articles for article (PubMed ID: 10361249)
1. Antibody-independent classical complement pathway activation and homologous C3 deposition in xeroderma pigmentosum cell lines.
Kurita M; Matsumoto M; Tsuji S; Kawakami M; Suzuki Y; Hayashi H; Toyoshima K; Seya T
Clin Exp Immunol; 1999 Jun; 116(3):547-53. PubMed ID: 10361249
[TBL] [Abstract][Full Text] [Related]
2. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
Matsumoto M; Sugita Y; Seya T
Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
[TBL] [Abstract][Full Text] [Related]
3. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
Iwata K; Seya T; Ariga H; Nagasawa S
J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
[TBL] [Abstract][Full Text] [Related]
4. Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1.
Collard CD; Montalto MC; Reenstra WR; Buras JA; Stahl GL
Am J Pathol; 2001 Sep; 159(3):1045-54. PubMed ID: 11549596
[TBL] [Abstract][Full Text] [Related]
5. Human IgA activates the complement system via the mannan-binding lectin pathway.
Roos A; Bouwman LH; van Gijlswijk-Janssen DJ; Faber-Krol MC; Stahl GL; Daha MR
J Immunol; 2001 Sep; 167(5):2861-8. PubMed ID: 11509633
[TBL] [Abstract][Full Text] [Related]
6. Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation.
Kuraya M; Ming Z; Liu X; Matsushita M; Fujita T
Immunobiology; 2005; 209(9):689-97. PubMed ID: 15804047
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
Seya T; Hara T; Matsumoto M; Akedo H
J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
[TBL] [Abstract][Full Text] [Related]
8. Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them.
Seya T; Hara T; Okada M; Kojima A; Matsumoto M; Akedo H
Int Immunol; 1992 Dec; 4(12):1361-71. PubMed ID: 1283697
[TBL] [Abstract][Full Text] [Related]
9. Complement activation by C-reactive protein on the HEp-2 cell substrate.
Vaith P; Prasauskas V; Potempa LA; Peter HH
Int Arch Allergy Immunol; 1996 Oct; 111(2):107-17. PubMed ID: 8859218
[TBL] [Abstract][Full Text] [Related]
10. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
Hair PS; Gronemus JQ; Crawford KB; Salvi VP; Cunnion KM; Thielens NM; Arlaud GJ; Rawal N; Krishna NK
Mol Immunol; 2010 Jan; 47(4):792-8. PubMed ID: 19896716
[TBL] [Abstract][Full Text] [Related]
11. A keratin peptide inhibits mannose-binding lectin.
Montalto MC; Collard CD; Buras JA; Reenstra WR; McClaine R; Gies DR; Rother RP; Stahl GL
J Immunol; 2001 Mar; 166(6):4148-53. PubMed ID: 11238665
[TBL] [Abstract][Full Text] [Related]
12. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism.
Ambrosio AR; De Messias-Reason IJ
Parasite Immunol; 2005 Sep; 27(9):333-40. PubMed ID: 16149991
[TBL] [Abstract][Full Text] [Related]
13. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.
Gullstrand B; Mårtensson U; Sturfelt G; Bengtsson AA; Truedsson L
Clin Exp Immunol; 2009 May; 156(2):303-11. PubMed ID: 19302245
[TBL] [Abstract][Full Text] [Related]
14. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans.
Boxx GM; Nishiya CT; Kozel TR; Zhang MX
Mol Immunol; 2009 Jan; 46(3):473-80. PubMed ID: 19038459
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry based detection of HLA alloantibody mediated classical complement activation.
Wahrmann M; Exner M; Regele H; Derfler K; Körmöczi GF; Lhotta K; Zlabinger GJ; Böhmig GA
J Immunol Methods; 2003 Apr; 275(1-2):149-60. PubMed ID: 12667679
[TBL] [Abstract][Full Text] [Related]
17. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy.
Endo M; Ohi H; Ohsawa I; Fujita T; Matsushita M; Fujita T
Nephrol Dial Transplant; 1998 Aug; 13(8):1984-90. PubMed ID: 9719152
[TBL] [Abstract][Full Text] [Related]
18. Glomerular deposition of mannose-binding lectin in human glomerulonephritis.
Lhotta K; Würzner R; König P
Nephrol Dial Transplant; 1999 Apr; 14(4):881-6. PubMed ID: 10328463
[TBL] [Abstract][Full Text] [Related]
19. Antibody-independent binding and activation of complement by Schistosoma mansoni adult worms.
Linder E; Huldt G
Parasite Immunol; 1983 Mar; 5(2):183-94. PubMed ID: 6601790
[TBL] [Abstract][Full Text] [Related]
20. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
